Lineage Cell Therapeutics, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Lineage Cell Therapeutics, Inc. (LCTX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $15.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-08-06
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $15.00M.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $16.00M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $6.20M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.50M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $15.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $16.00M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $6.20M 10-K · filed 2026-03-05 |
| 2025-09-30 | $7.50M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $8.50K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $9.70K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $8.20M 10-K · filed 2025-03-10 |
| 2024-09-30 | $9.50M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $10.50M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $11.40M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $8.60M 10-K · filed 2024-03-07 |
| 2014-12-31 | $8.39M 10-K · filed 2015-03-11 |
| 2013-12-31 | $5.61M 10-K · filed 2014-03-17 |
| 2012-12-31 | $3.19M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |